本文已被：浏览 1311次 下载 7次
中文摘要: 目的 探讨阿莫西林和阿莫西林-克拉维酸钾的不良反应情况。方法 选取佳木斯大学附属第一医院180例支气管感染患者进行分析研究，分成对照组和观察组，各有90例患者，对照组患者给予阿莫西林治疗，观察组给予阿莫西林-克拉维酸钾治疗，比较两组患者的不良反应情况。结果 观察组患者的不良反应发生率低于对照组，差异有统计学意义(P＜0.05)。两组的治疗效果对比，观察组优于对照组，差异有统计学意义(P＜0.05)。结论 感染性疾病患者接受阿莫西林-克拉维酸钾治疗的安全性高于阿莫西林，临床应用安全性较高。
中文关键词: 阿莫西林 阿莫西林-克拉维酸钾 不良反应
Abstract:OBJECTIVE To investigate the adverse reactions of amoxicillin and amoxicillin and clavulanate potassiun.METHODS In Jiamusi university first affiliated hospital,180 cases of patients with bronchial infection diseases were divided into control group an observation group,90 cases in each group.Patients in the control group received amoxicillin for treatment,the observation group received amoxicillin and clavulanic potassium,compared two groups of patients with adverse reactions. RESULTS The incidence of adverse reactions in the observation group was lower than that in the control group,the difference was significant（P<0.05）.The therapeutic effect of the two groups was compared,the observation group was better than the control group,and the results were statistically significant（P<0.05）. CONCLUSION It is safe to use amoxicillin and clavulanate potassium for patients with infectious diseases,and the clinical application safety is high.
文章编号：3201804027 中图分类号：R978.1 文献标志码：
基金项目:
| 作者 | 单位 |
| 胡俊华①，孟秋媛②，胡艳秋③＃ |
| Author Name | Affiliation |
引用文本：